PMID: 7025334Mar 1, 1981Paper

Randomised controlled trial of rehabilitation in chronic respiratory disability

Thorax
A CockcroftG Berry

Abstract

A randomised controlled study of the effects of exercise training in 39 patients with chronic respiratory disability was performed. Exercise training began with six weeks in a rehabilitation centre and was continued at home. The original control group attended the rehabilitation centre after the controlled part of the study. The treated group experienced subjective benefit from rehabilitation. The 12-minute walking distance increased on average from 523 m to 643 m in the treatment group and from 564 m to 607 m in the control group. The treatment effect of 77 m (SE 33 m) was significant at the 5% level. Treadmill exercise performance changed little and resting lung function was unaltered after rehabilitation. The treatment group maintained most of their improvement seven months later and the original control subjects improved after their rehabilitation. The study confirms the beneficial effects of exercise training in the chronically breathless and it suggests that the 12-minute walking distance is a useful index of changes in everyday exercise tolerance.

References

May 1, 1978·British Journal of Cancer·S J White, L S Freedman
Jan 1, 1978·Respiration; International Review of Thoracic Diseases·D J MertensT Kavanagh
Apr 3, 1976·British Medical Journal·C R McGavinG J McHardy
Dec 1, 1967·Archives of Internal Medicine·D E Dines, T W Parkin
Jan 1, 1971·Internationale Zeitschrift für angewandte Physiologie, einschliesslich Arbeitsphysiologie·J A Maynard, C M Tipton
Jul 1, 1972·British Journal of Diseases of the Chest·J E Cotes
Oct 1, 1972·Journal of Neurology, Neurosurgery, and Psychiatry·P CastaigneM Petrover
Apr 20, 1968·British Medical Journal·D Christie
Feb 23, 1980·British Medical Journal·D J Sinclair, C G Ingram
Jan 1, 1964·Archives of Internal Medicine·A K PIERCEW F MILLER

❮ Previous
Next ❯

Citations

Aug 1, 1986·Clinical Reviews in Allergy·A I Terr
Aug 1, 1996·The Annals of Thoracic Surgery·K S Naunheim, M K Ferguson
Feb 24, 2000·International Journal of Nursing Studies·S P Small, M Lamb
Nov 19, 1994·Lancet·R S GoldsteinG H Guyatt
Sep 1, 1989·Respiratory Medicine·A D Morgan
Jan 1, 1996·Journal of Cardiopulmonary Rehabilitation·B Steele
Nov 1, 1996·Journal of Cardiopulmonary Rehabilitation·J H StrijbosG H Koëter
Jun 19, 1998·Journal of Cardiopulmonary Rehabilitation·M J Berry, S A Walschlager
Dec 3, 2009·Journal of Cardiopulmonary Rehabilitation and Prevention·L SundararajanS Packham
Dec 24, 1997·Respirology : Official Journal of the Asian Pacific Society of Respirology·N Roche, G J Huchon
Jun 2, 2007·Respirology : Official Journal of the Asian Pacific Society of Respirology·Meng-Jer HsiehYing-Huang Tsai
Mar 1, 1984·Postgraduate Medical Journal·D M Geddes
Nov 1, 1984·Thorax·G H GuyattD W Taylor
Mar 22, 2005·American Journal of Respiratory and Critical Care Medicine·Thierry TroostersMarc Decramer
May 14, 2009·International Journal of Chronic Obstructive Pulmonary Disease·Christopher B Cooper
Oct 17, 2013·American Journal of Respiratory and Critical Care Medicine·Martijn A SpruitUNKNOWN ATS/ERS Task Force on Pulmonary Rehabilitation
Mar 22, 2003·Journal of General Internal Medicine·Ghassan F SalmanDavid R Calkins
Apr 26, 2006·Respiration; International Review of Thoracic Diseases·Micaela RomagnoliEnrico M Clini
May 31, 2014·Clinics in Chest Medicine·Rachael A Evans, Michael D L Morgan
Aug 1, 1997·Chest·R S GoldsteinD Feeny
Dec 13, 2005·Revue des maladies respiratoires·T Urban

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.